Roche

Roche’s hemophilia drug slashes bleeding rate, boosting blockbuster projections — but doubts on safety linger
Endpoints
Mon, 06/26/17 - 09:54 am
Roche
hemophilia A
ACE910
emicizumab
clinical trials
Roche's Ocrevus racks up more positive MS data in relapsing and primary progressive forms
Fierce Pharma
Sat, 06/24/17 - 09:14 am
Roche
Ocrevus
MS
multiple sclerosis
FDA says yes to rapid-acting Rituxan
BioPharma Dive
Fri, 06/23/17 - 11:23 am
FDA
Roche
Rituxan Hycela
refractory follicular lymphoma
CLL
diffuse large B-cell lymphoma
Novartis wins another biosimilar round with an OK for its Rituxan copycat
Endpoints
Mon, 06/19/17 - 03:16 pm
Novartis
biosimilars
Rituxan
Roche
Sandoz
Pfizer, Roche and Aspen face South African probe into cancer drug prices
Reuters
Tue, 06/13/17 - 05:50 pm
Pfizer
Roche
Aspen Pharmacare
South Africa
drug pricing
Roche ditches work on NewLink’s IDO cancer candidate
Fierce Biotech
Thu, 06/8/17 - 09:39 am
Roche
NewLink Genetics
indoximod
metastatic breast cancer
ASCO17: Roche's Alecensa bests Xalkori in lung study
BioPharma Dive
Mon, 06/5/17 - 12:11 pm
Roche
Alecensa
Xalkori
ASCO 2017
Pfizer
lung cancer
Takeda, sporting a new-look portfolio, revs for Roche battle in ALK lung cancer
Fierce Pharma
Mon, 06/5/17 - 12:08 pm
Takeda
Roche
ALK inhibitors
ASCO 2017
lung cancer
Novartis' Zykadia piles pressure on Pfizer's Xalkori, Roche's Alecensa with new lung cancer nod
Fierce Pharma
Wed, 05/31/17 - 09:32 am
Novartis
Zykadia
Pfizer
Xalkori
Roche
Alecensa
non-small cell lung cancer
Prescribed Reading: FDA on a roll, while pharma continues sell off
BioPharma Dive
Tue, 05/30/17 - 10:07 am
FDA
Roche
Ocrevus
Puma Biotechnology
neratinib
Novartis
Roche launches Accu-Chek Guide blood glucose meter
Mass Device
Tue, 05/30/17 - 10:04 am
Roche
devices
blood glucose monitoring
glucose meters
Accu-Chek
Roche looks into PML report for Ocrevus patient
BioPharma Dive
Thu, 05/25/17 - 11:25 am
Roche
PML
Ocrevus
Genentech
MS
multiple sclerosis
Roche debuts latest blood glucose meter, savings program
Fierce Biotech
Wed, 05/24/17 - 10:52 am
Roche
devices
blood glucose monitoring
diabetes
Accu-Chek
New Indication for Roche’s Actemra Means First FDA Approved Drug to Treat Giant Cell Arteritis
RAPS.org
Mon, 05/22/17 - 12:47 pm
Roche
Actemra
FDA
giant cell arteritis
tocilizumab
7 Areas to watch from the ASCO abstracts
BioPharma Dive
Fri, 05/19/17 - 11:35 am
ASCO 2017
oncology
Incyte
Merck
Eli Lilly
CAR-T
NewLink Genetics
Amgen
Roche
Kite Pharma
Juno Therapeutics
Merck’s checkpoint star Keytruda grabs another FDA OK, steering past wreckage of a Roche disaster
Endpoints
Fri, 05/19/17 - 10:12 am
Merck
Keytruda
FDA
Roche
Tecentriq
In a stunning setback, Roche says its top cancer drug Tecentriq failed a key PhIII study
Endpoints
Wed, 05/10/17 - 10:13 am
Roche
Tecentriq
clinical trials
bladder cancer
Amid sales growth, Roche plans defense from biosimilar threats
BioPharma Dive
Fri, 04/28/17 - 10:30 am
Roche
biosimilars
Rituxan
Herceptin
Avastin
Roche silently whisks away its $1.7B Seragon drug in a Q1 footnote
Endpoints
Thu, 04/27/17 - 09:25 am
Roche
Seragon
earnings
breast cancer
Q1 Earnings Preview: AbbVie, AstraZeneca, BMS, Celgene, Roche, Sanofi
BioPharma Dive
Wed, 04/26/17 - 09:29 pm
earnings
AbbVie
AstraZeneca
Bristol-Myers Squibb
Celgene
Roche
Sanofi

Pages